Federal contract award
75N98122F00001
BASE AWARD - FDA CDRH DIGITAL TRANSFORMATION 2.0 - BOOZ ALLEN HAMILTON
Award details
Obligations, current value and potential value describe different measures; they are never added together.
| Field | Reported value |
|---|---|
| Agency | Department of Health and Human Services |
| Office | NIH NITAA DITA-DVI OF INFO TECH ACQ |
| NAICS | 541512 — Computer Systems Design Services |
| PSC | DA01 — Support services for activities involved with application development and support to include analysis, design, development, coding, testing, and release packaging, as well as support of off-the-shelf Business Applications. |
| Parent award / vehicle | HHSN316201200008W |
| Set-aside | Not reported |
| Pricing type | FIRM FIXED PRICE |
| Obligations | $195.6M |
| Current contract value | $195.6M |
| Potential contract value / ceiling | $309.6M |
| Start date | Sep 30, 2022 |
| Current end date | Sep 29, 2026 |
| Potential end date | Sep 26, 2027 |
| Latest award activity | Sep 2, 2026 |
| Source loaded | Sep 19, 2026 |
Funding and modification history
Showing the latest 30 of 30 loaded transactions. Negative values are deobligations.
| Date | Modification | Obligation change | Description |
|---|---|---|---|
| Sep 2, 2026 | P00029 | $-400.0K | CDRH DIGITAL TRANSFORMATION SERVICES |
| May 20, 2026 | P00028 | $0 | ADMINISTRATIVE MODIFICATION TO UPDATE/CORRECT THE PERIOD OF PERFORMANCE END DATE. |
| Feb 10, 2026 | P00027 | $22.0M | THE PURPOSE OF THIS MODIFICATION IS TO EXERCISE OPTION PERIOD 2B AND MODIFY THE PREVIOUS CLIN STRUCTURE AS FOLLOWS: ADD AND EXERCISE THE FOLLOWING CLINS FOR OPTION PERIOD 2B: CLIN 3042: OPTION PERIOD 2B PROJECT MANAGEMENT IN THE AMOUNT OF $1,776, |
| Nov 14, 2025 | P00026 | $418.0K | THE PURPOSE OF THIS MODIFICATION IS TO 1.) OBLIGATE FUNDS FOR PROGRAM MANAGEMENT, 2.) CHANGE PERIODS OF PERFORMANCE AND 3.) INCORPORATE THE REVISED PERFORMANCE WORK STATEMENT. |
| Nov 10, 2025 | P00025 | $-485.7K | THE PURPOSE OF THIS MODIFICATION IS TO DEOBLIGATE RESIDUAL FUNDS FROM CLINS 35 AND 37 IN THE BASE YEAR PERIOD. |
| Sep 26, 2025 | P00024 | $5.8M | THE PURPOSE OF THIS MODIFICATION IS TO EXERCISE OPTION YEAR 2 AS IDENTIFIED BELOW: 1.EXERCISE OF CLINS THE FOLLOWING PREVIOUSLY UNEXERCISED CLINS ARE HEREBY EXERCISED: CLIN 2001: PROGRAM MANAGMENT CLIN 2004: ADDITIONAL PROJECTS - COMMISSIONER P |
| Nov 14, 2024 | P00022 | $0 | THE PURPOSE OF BILATERAL MODIFICATION P00022 IS TO UPDATE THE KEY PERSONNEL TABLE ON PAGE 68 TO MAKE THE FOLLOWING CHANGES: - REMOVE BUSINESS ARCHITECTURE ROLE THE PROGRAM OFFICE NO LONGER HAS A BONAFIDE NEED FOR THE KEY PERSONNEL ROLE OF BUSINESS |
| Nov 14, 2024 | P00023 | $26.7M | MODIFICATION P00023 EXERCISES AND FULLY FUNDS OY 1 CLINS 11/14/2024-09/29/2025 FOR $26,693,288.03.THE TOTAL OBLIGATED FUNDING CHANGED FROM: $141,492,300.92 TO 168,185,588.95 (AN INCREASE OF $26,693,288.03). THE TOTAL LIFECYCLE AWARD VALUE REMAINS |
| Sep 9, 2024 | P00020 | $0 | MODIFICATION P00020 CHANGES THE POP FROM 12 MONTH 09/30/2024-09/29/2025 TO POP 270 DAYS AFTER THE AWARD OF OPTION YEAR 1 FOR CLIN 1016, 1028 AND 1029. CLIN 1041 CHANGES TO 12 MONTHS 09/30/2024-09/29/2025. THE REQUIREMENTS AND THE CONTRACT PRICING REM |
| Sep 9, 2024 | P00021 | $23.5M | MODIFICATION P00021 EXERCISES AND FULLY FUNDS OY 1 - 12 MONTH 09/30/2024-09/29/2025 FOR $23,495,898.80. THE REMAINING CLINS FOR OY1 ARE OPTIONAL AND UNFUNDED AND HAVE WITHIN 270 DAYS AFTER THE AWARD OF OY1 TO BE EXERCISED. THE TOTAL OBLIGATED FUNDING |
| Sep 4, 2024 | P00019 | $0 | THE PURPOSE OF MODIFICATION P00019 IS TO REALIGN CLIN DESCRIPTIONS, STRUCTURES, AND VALUES FOR OPTION YEAR 1 TO ALIGN WITH THE BASE PERIOD. THIS MODIFICATION WILL ALLOW CLINS FOR OY1 TO BE EXERCISED AND FUNDED AS WELL AS ALLOWING OTHER LIKE OPTIONAL |
| Jul 12, 2024 | P00018 | $264.9K | THE PURPOSE OF THIS MODIFICATION P00018 IS TO EXERCISE AND FUND CLINS 0041 BASE PERIOD ADTL PROJ AND PROG $198,324.00 AND 0043 DT CORE ODCS MATERIALS $66,555.00. THIS MODIFICATION REALLOCATES UNUSED CONTRACT CEILING WITH THE CREATION OF TWO NEW CLINS |
| Mar 4, 2024 | P00017 | $6.4M | THE PURPOSE OF THIS MODIFICATION P00017 IS TO EXERCISE CLINS 0027, 0044, AND 0045 FOR A TOTAL CPFF OF $6,368,936.68 FOR THE BASE PERIOD. THIS MODIFICATION CORRECTS A SYSTEM ERROR IN WHICH CLIN 0045 WAS NOT REDUCED IN PRISM TO THE NEW VALUE FOR INCR |
| Jan 29, 2024 | P00016 | $0 | MODIFICATION P00016 THE PURPOSE OF THIS UNILATERAL MODIFICATION IS TO REMOVE AND REPLACE ELIZABETH MCNAMARA AS THE FDA DIGITAL TRANSFORMATION PROGRAM DIRECTOR (EQUIVALENT TO GOVERNMENT TASK MANAGER-GTM) WITH BRIANNA BRODERICK. REMOVE AND REPLACES T |
| Dec 15, 2023 | P00015 | $0 | MODIFICATION P00015 RE-DESCRIBES BASE PERIOD CLINS TO ENSURE FINANCIAL SOLVENCY, ACCOUNTABILITY OF WORK PERFORMANCE AND VENDOR FINANCIAL PROJECT TRACKING WITHIN CLINS. THE CEILING REMAINS UNCHANGED. THIS REQUEST COMPLIES WITH THE CURRENT STRUCTURE, A |
| Aug 31, 2023 | P00014 | $5.9M | THE PURPOSE IS TO CANCEL THE STOP WORK ORDER. MODIFICATION P00014 IS TO ADD $5,877,000.00 TO SUPPORT THE LIMITATION OF FUNDS IN WHICH NO ADDITIONAL FEE IS BEING SUPPORTED. THIS MODIFICATION ALSO CANCELS THE STOP WORK ORDER FOR CLIN 0010. BASE PERIOD |
| Aug 24, 2023 | P00013 | $0 | BASE PERIOD -STOP WORK ORDER ISSUED. NO WORK TO PROCEED UNTIL CANCELLATION OF THE ORDER CLIN 0010 DISCOVERY CPFF POP 09/30/2022-09/29/2024. REMOVE PRISCILLA MAGNUSEN REPLACED WITH WILLIAM SMITH. |
| Jul 5, 2023 | P00012 | $0 | THE PURPOSE OF UNILATERAL MODIFICATION P00012 IS TO UPDATE THE KEY PERSONNEL TABLE ON PAGE 68 TO MAKE THE FOLLOWING CHANGES: REMOVE ADAM CORDERO AS DATA ARCHITECT - BUSINESS ANALYST LEVEL III AND REPLACE WITH ATIF SIDDIQUI. REMOVE AMIR VENEGAS AS O |
| Jun 30, 2023 | P00011 | $-3.9M | THE PURPOSE OF MODIFICATION P00011 IS TO CANCEL CLIN 0039 IN ITS ENTIRETY AND DE-OBLIGATE ALL FUNDING IN THE AMOUNT OF $3,896,535.27. THE FUNDING OBLIGATED UNDER CLIN 0039 WITH MODIFICATION 10, WAS OBLIGATED ON JUNE 6, 2023. PER THE PROGRAM, THIS |
| Jun 6, 2023 | P00010 | $3.9M | THE PURPOSE OF BI-LATERAL MODIFICATION P00010 IS TO EXERCISE AND FUND THE FOLLOWING CLIN: OPTIONAL BASE PERIOD - CLIN 0039 OPTIONAL SHIELD (RSCSP) INCREMENT 1 OF 2 (CPFF) IN ACCORDANCE WITH BAH PROPOSALS DATED 09/20/2022. OPTIONAL UNFUNDED CLIN 00 |
| Jun 2, 2023 | P00009 | $5.8M | THE PURPOSE OF BI-LATERAL MODIFICATION P00009 IS TO EXERCISE AND FUND THE FOLLOWING CLIN: OPTIONAL BASE PERIOD - CLIN 0042 DT CORE ODCS MATERIALS - INCREMENT 3 OF 4 (CR) IN ACCORDANCE WITH BAH PROPOSALS DATED 09/20/2022. OPTIONAL CLIN 0042 $5,844, |
| Jun 1, 2023 | P00008 | $28.1M | THE PURPOSE OF MODIFICATION P00008 IS TO EXERCISE AND FUND THE FOLLOWING CLINS: OPTIONAL BASE PERIOD - CLIN 0028 DT CORE PROJECTS ODCS MATERIALS (CR) - $5,000,000.00 OPTIONAL BASE PERIOD - CLIN 0031 OPTIONAL CFQ/ADVANCED MANUFACTURING (MDSAP) (CPF |
| May 15, 2023 | P00007 | $794.3K | THE PURPOSE OF MODIFICATION P00007 MODIFICATION P00007 EXERCISE AND FUND CLIN 0036 INCREMENT A $794,324.15 AND CREATE CLIN 0041 - INCREMENT B FOR BALANCE OF PROPOSAL COAST $1.684M- BASE PERIOD OSEL REQUIREMENTS AND ADD ALTERNATE COR TASHA MCMILLAN A |
| Apr 12, 2023 | P00006 | $0 | THE PURPOSE OF MODIFICATION P00006 IS TO PERFORM THE FOLLOWING ACTIONS: 16.2 DATA AND INTELLECTUAL RIGHTS (REVISED IN ACCORDANCE WITH MODIFICATION P00006) THE GOVERNMENT HAS DETERMINED THAT SECTION 16.2 DATA AND INTELLECTUAL RIGHTS SHALL BE MODIF |
| Feb 13, 2023 | P00005 | $0 | THE PURPOSE OF MODIFICATION P00005 IS TO PERFORM THE FOLLOWING ACTIONS: 1 - THE TASK ORDER CHANGES THE DIGITAL TRANSFORMATION PROGRAM MANAGER FROM KUMAR MUCHADO TO POONAM SACHDEVA. MS. SACHDEVA HAS COMPLETED ALL OF THE REQUIRED HHS LEVEL 3 REQUI |
| Nov 23, 2022 | P00004 | $0 | THE PURPOSE OF UNILATERAL ADMINISTRATIVE MODIFICATION P00004 IS TO UPDATE THE KEY PERSONNEL TABLE ON PAGE 68: - DATA ARCHITECT/BUSINESS ANALYST III: REPLACE JEREMY WALSH WITH ADAM CORDERO. ALL OTHER TERMS AND CONDITIONS REMAIN UNCHANGED. |
| Nov 21, 2022 | P00003 | $0 | MODIFICATION P00003 IS AN ADMINISTRATIVE CORRECTION FOR GENERAL TAB - CONTACTS/OFFICES FOR PAYMENT OFFICE FROM CPD DITA-NITAAC TO ASSISTED-NITAAC |
| Oct 11, 2022 | P00002 | $0 | MODIFICATION P00002 IS AN ADMINISTRATIVE CORRECTION FOR GENERAL TAB - DATES FOR THE CURRENT BASE PERIOD COMPLETION DATE 09/29/2024. |
| Sep 29, 2022 | 0 | $70.8M | BASE AWARD - FDA CDRH DIGITAL TRANSFORMATION 2.0 - BOOZ ALLEN HAMILTON |
| Sep 29, 2022 | P00001 | $0 | MODIFICATION P00001 IS AN ADMINISTRATIVE CORRECTION FOR TYPOS IN THE CLIN DESCRIPTION 1005 AND 2003. |
Estimated positioning window
Oct 25, 2026 – Mar 26, 2027
Recompete signal: . Rule-based research score; positioning dates are estimates.
85/100
Why this recompete signal
Contract timing and recorded acquisition signals at the time of calculation.
Stored score: 85/100. Available recorded signals: 80 points.
- Contract end 2027-09-26 (336 days from calculation)
- +35 points
- 65 historical awards in this buyer and category group
- +15 points
- 30 recorded award transactions
- +10 points
- Latest award action: 2026-09-02
- +5 points
- Parent award identifier recorded
- +5 points
- Solicitation identifier recorded
- +10 points
- Linked official forecast
- +0 points
- Calculated on
- 2026-10-25 10:18:04.631876+00:00
The historical group combines buyer, NAICS, and PSC. Multiple awards in this group do not by themselves establish repeated competitions.
Rule-based research score; it does not measure your chance of winning.
This older calculation does not retain a complete reproducible breakdown. Missing or changed inputs are not assigned invented points: Original award-value bonus input.
Recompete score calculated Oct 25, 2026.
Research next steps
- Check the linked forecast or SAM for a confirmed solicitation and current timing.
- Verify whether remaining options may extend performance beyond the current end date.
- Confirm the ordering vehicle and your eligibility or a qualified teaming route.
- Review the award scope and buyer evidence before making a bid/no-bid decision.